Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Non-Current Assets (2010 - 2026)

Omnicell's (OMCL) quarterly Non-Current Assets came in at $1.3 billion in Q2 2026, down 2.86% year-over-year from $1.3 billion in Q2 2025, and down 1.43% quarter-over-quarter from $1.3 billion in Q1 2026.

Analysis

Omnicell (OMCL) Non-Current Assets (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Non-Current Assets for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 2.86% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $5.1 billion, a 1.56% decrease from a year earlier, with the FY2025 full-year figure at $1.3 billion, down 0.83% from the prior year.
  • Non-Current Assets was $1.3 billion for Q2 2026 at Omnicell, down from $1.3 billion in the prior quarter.
  • Over five years, Non-Current Assets peaked at $1.3 billion in Q1 2022 and troughed at $1.3 billion in Q2 2026.
  • A 5-year average of $1.3 billion and a median of $1.3 billion in 2024 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets jumped 37.57% in 2022 and slipped 2.86% in 2026, its largest moves.
  • Over 5 years, Non-Current Assets stood at $1.3 billion in 2022, then fell by 2.23% to $1.3 billion in 2023, then gained by 0.47% to $1.3 billion in 2024, then fell by 0.83% to $1.3 billion in 2025, then slipped by 2.41% to $1.3 billion in 2026.
  • The last three Non-Current Assets figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 11.33 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 68.92 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 7.05 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 24.47 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 2.37 Bn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 4.64 Bn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 1.26 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.26 Bn
Mar 31, 2026 1.28 Bn
Dec 31, 2025 1.29 Bn
Sep 30, 2025 1.29 Bn
Jun 30, 2025 1.30 Bn
Mar 31, 2025 1.31 Bn
Dec 31, 2024 1.31 Bn
Sep 30, 2024 1.29 Bn
Jun 30, 2024 1.30 Bn
Mar 31, 2024 1.29 Bn
Dec 31, 2023 1.30 Bn
Sep 30, 2023 1.31 Bn
Jun 30, 2023 1.31 Bn
Mar 31, 2023 1.32 Bn
Dec 31, 2022 1.33 Bn
Sep 30, 2022 1.33 Bn
Jun 30, 2022 1.34 Bn
Mar 31, 2022 1.35 Bn
Dec 31, 2021 1.36 Bn
Sep 30, 2021 1.16 Bn